| Serial Number | 90285221 |
| Word Mark | 3RDEYEBIO |
| Filing Date | Wednesday, October 28, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 22, 2022 |
| Registration Number | 6675094 |
| Registration Date | Tuesday, March 22, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 4, 2022 |
| Pseudo Mark | THIRD EYE BIO |
| Goods and Services | Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenomics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning application; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer, stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 20, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, March 1, 2020 |
| First Use In Commerce Date | Sunday, March 1, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 20, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, March 1, 2020 |
| First Use In Commerce Date | Sunday, March 1, 2020 |
| Party Name | 3RDEYEBIO LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seattle, WA 98115 |
| Party Name | 3RDEYEBIO LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seattle, WA 98115 |
| Party Name | 3RDEYEBIO LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seattle, WA 98115 |
| Event Date | Event Description |
| Tuesday, March 22, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 4, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 4, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 15, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 1, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 1, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 1, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 1, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 1, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 1, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, July 1, 2021 | LETTER OF SUSPENSION E-MAILED |
| Thursday, July 1, 2021 | SUSPENSION LETTER WRITTEN |
| Tuesday, June 1, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 1, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 1, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, April 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, April 3, 2021 | NON-FINAL ACTION E-MAILED |
| Saturday, April 3, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, March 29, 2021 | ASSIGNED TO EXAMINER |
| Sunday, December 20, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Sunday, November 1, 2020 | NEW APPLICATION ENTERED IN TRAM |